https://www.selleckchem.com/products/GDC-0941.html
To evaluate if the hyperdense middle cerebral artery sign (HMCAS) is an imaging biomarker for hemorrhagic transformation (HT) and the functional outcome of patients with large cerebral infarctions without thrombolytic therapy. The clinical and imaging data of 312 patients with large cerebral infarction without thrombolytic therapy were retrospectively analyzed. They were divided into patients who presented with HMCAS (n=121) and those who did not (non-HMCAS[n=168] patients), and the clinical data of the 2 groups were compared. This was
Like
Comment
Share
